NCT04852432View on ClinicalTrials.gov

Evaluation of the Efficacy of Oxygen Therapy and Clinical Feasibility of High Flow Nasal Cannula During Moderate and Deep Sedation in Pediatric Patients

NARecruitingINTERVENTIONAL

Enrollment

258

Participants

Timeline

Start Date

July 27, 2021

Primary Completion Date

April 30, 2024

Study Completion Date

December 30, 2024

Conditions

Pediatric Sedation

Interventions

DEVICE

high flow nasal cannula

The heated air is administered at a rate of 2L/kg/min using an Optiflow device (Fisher and Paykel Healthcare, Auckland, New Zealand). Inhalation oxygen concentration starts with 50%.

DEVICE

nasal prong

Oxygen is administered via nasal prong

Trial Locations (1)

110-744

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors

lead

Seoul National University Hospital

OTHER